These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 10515039)
1. [Garlic effectiveness in rheumatoid arthritis]. Denisov LN; Andrianova IV; Timofeeva SS Ter Arkh; 1999; 71(8):55-8. PubMed ID: 10515039 [TBL] [Abstract][Full Text] [Related]
2. Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab. Lequerré T; Jouen F; Brazier M; Clayssens S; Klemmer N; Ménard JF; Mejjad O; Daragon A; Tron F; Le Loët X; Vittecoq O Rheumatology (Oxford); 2007 Mar; 46(3):446-53. PubMed ID: 16899502 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy of D-penicillamine and methotrexate in the treatment of rheumatoid arthritis in relation to levels of circulating rheumatoid factors of different classes]. Zborovskiĭ AB; Sivordova LE; Derevianko LI; Zborovskaia IA; Zavodovskiĭ BV Ter Arkh; 1999; 71(1):60-3. PubMed ID: 10097305 [TBL] [Abstract][Full Text] [Related]
4. The safety and effectiveness of a chloroform/methanol extract of Tripterygium wilfordii Hook F (T2) plus methotrexate in treating rheumatoid arthritis. Zhang W; Shi Q; Zhao LD; Li Y; Tang FL; Zhang FC; Zhang X J Clin Rheumatol; 2010 Dec; 16(8):375-8. PubMed ID: 21085018 [TBL] [Abstract][Full Text] [Related]
5. Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy. Pavelka K; Jarosová K; Suchý D; Senolt L; Chroust K; Dusek L; Vencovský J Ann Rheum Dis; 2009 Aug; 68(8):1285-9. PubMed ID: 19351624 [TBL] [Abstract][Full Text] [Related]
7. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor. Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547 [TBL] [Abstract][Full Text] [Related]
8. A pilot trial evaluating Meta050, a proprietary combination of reduced iso-alpha acids, rosemary extract and oleanolic acid in patients with arthritis and fibromyalgia. Lukaczer D; Darland G; Tripp M; Liska D; Lerman RH; Schiltz B; Bland JS Phytother Res; 2005 Oct; 19(10):864-9. PubMed ID: 16261517 [TBL] [Abstract][Full Text] [Related]
9. Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate. Lu LJ; Bao CD; Dai M; Teng JL; Fan W; Du F; Yang NP; Zhao YH; Chen ZW; Xu JH; He PG; Wu HX; Tao Y; Zhang MJ; Han XH; Li XF; Gu JR; Li JH; Yu H Arthritis Rheum; 2009 Jul; 61(7):979-87. PubMed ID: 19565542 [TBL] [Abstract][Full Text] [Related]
10. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations. Kremer JM; Weinblatt ME; Bankhurst AD; Bulpitt KJ; Fleischmann RM; Jackson CG; Atkins KM; Feng A; Burge DJ Arthritis Rheum; 2003 Jun; 48(6):1493-9. PubMed ID: 12794815 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis]. Gubar' EE; Bochkova AG; Bunchuk NV Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110 [TBL] [Abstract][Full Text] [Related]
12. [Neopterin: laboratory marker of cellular immunity activation in rheumatoid arthritis]. Nasonov EL; Samsonov MIu; Chichasova NV; Imametdinova GR; Nikiforova EL; Aleksandrova EN; Ilich-Stoyanovich O; Fux D; Vaxter H Ter Arkh; 1998; 70(5):28-31. PubMed ID: 9644738 [TBL] [Abstract][Full Text] [Related]
13. Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis. Wolbink GJ; Voskuyl AE; Lems WF; de Groot E; Nurmohamed MT; Tak PP; Dijkmans BA; Aarden L Ann Rheum Dis; 2005 May; 64(5):704-7. PubMed ID: 15485995 [TBL] [Abstract][Full Text] [Related]
14. [Combined basic therapy of rheumatoid arthritis with methotrexate and plaquenil]. Sergiets NA; Erov NK Ter Arkh; 2009; 81(6):34-7. PubMed ID: 19663190 [TBL] [Abstract][Full Text] [Related]
15. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy. van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola EM; Pedersen R; Freundlich B; Chang DJ; Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331 [TBL] [Abstract][Full Text] [Related]
16. A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment. Durez P; Nzeusseu Toukap A; Lauwerys BR; Manicourt DH; Verschueren P; Westhovens R; Devogelaer JP; Houssiau FA Ann Rheum Dis; 2004 Sep; 63(9):1069-74. PubMed ID: 15308515 [TBL] [Abstract][Full Text] [Related]
17. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis. Nikolaisen C; Rekvig OP; Nossent HC Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159 [TBL] [Abstract][Full Text] [Related]
18. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies. de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Verpoort KN; Schreuder GM; Ewals JA; Terwiel JP; Ronday HK; Kerstens PJ; Toes RE; de Vries RR; Breedveld FC; Dijkmans BA; Huizinga TW; Allaart CF Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829 [TBL] [Abstract][Full Text] [Related]
19. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis. Lee SS; Park YW; Park JJ; Kang YM; Nam EJ; Kim SI; Lee JH; Yoo WH; Lee SI Scand J Rheumatol; 2009; 38(1):11-4. PubMed ID: 19191187 [TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis. Haringman JJ; Gerlag DM; Smeets TJ; Baeten D; van den Bosch F; Bresnihan B; Breedveld FC; Dinant HJ; Legay F; Gram H; Loetscher P; Schmouder R; Woodworth T; Tak PP Arthritis Rheum; 2006 Aug; 54(8):2387-92. PubMed ID: 16869001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]